The role of miR-124 as a pro-inflammatory molecule has been proposed in CD patients; in this case, miR-124 targets the aryl hydrocarbon receptor (AhR), which is downregulated in the gut of patients with IBD. This evidence concerns the gene AHR and inflammatory bowel disease.